US Stock MarketDetailed Quotes

Enveric Biosciences (ENVB)

Watchlist
  • 1.963
  • -0.077-3.77%
Close Apr 10 16:00 ET
  • 1.994
  • +0.031+1.55%
Post 20:01 ET
3.71MMarket Cap-0.05P/E (TTM)

Enveric Biosciences (ENVB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-5.38%-8.14M
-36.09%-1.78M
-123.82%-2.07M
34.58%-1.89M
7.96%-2.39M
45.18%-7.73M
25.10%-1.31M
66.17%-927.07K
35.31%-2.89M
49.42%-2.6M
Net income from continuing operations
8.39%-8.77M
30.45%-2.19M
10.09%-1.87M
-34.04%-2.52M
11.07%-2.18M
44.63%-9.57M
8.19%-3.15M
26.16%-2.08M
70.43%-1.88M
47.47%-2.46M
Operating gains losses
94.42%-2.57K
--0
--0
--0
88.03%-2.57K
95.55%-45.99K
99.19%-6.6K
100.10%623
-103.11%-18.57K
88.30%-21.44K
Depreciation and amortization
-40.48%200.86K
-52.13%39.49K
-52.40%40.37K
-52.84%39.98K
-5.13%81.02K
-17.29%337.49K
-2.36%82.49K
-11.50%84.81K
-25.88%84.78K
-24.64%85.41K
Other non cash items
-123.73%-99.23K
--29.45K
----
----
----
-77.37%418.2K
----
----
----
----
Change In working capital
30.08%-295.94K
-88.59%100.14K
-142.73%-299.95K
126.48%382.8K
14.00%-478.92K
-142.20%-423.24K
326.23%877.34K
188.11%701.91K
-584.66%-1.45M
39.63%-556.89K
-Change in prepaid assets
40.58%250.94K
-35.15%118.14K
-84.34%84.6K
-56.23%94.32K
93.93%-46.13K
2,703.12%178.5K
-75.35%182.17K
47.63%540.15K
-50.74%215.47K
50.99%-759.29K
-Change in payables and accrued expense
9.12%-546.88K
-102.59%-18.01K
-337.73%-384.56K
117.37%288.48K
-313.84%-432.8K
-479.44%-601.74K
230.29%695.17K
243.52%161.76K
-1,392.22%-1.66M
-69.04%202.4K
Cash from discontinued investing activities
Operating cash flow
-5.38%-8.14M
-36.09%-1.78M
-123.82%-2.07M
34.58%-1.89M
7.96%-2.39M
45.18%-7.73M
25.10%-1.31M
66.17%-927.07K
35.31%-2.89M
49.42%-2.6M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
Net PPE purchase and sale
----
----
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
37.86%10.58M
480.25%2.69M
478.02%2.99M
1,204.37%449.1K
-33.18%4.45M
671.33%7.67M
349.05%463.45K
593.04%517.69K
103.27%34.43K
6.66M
Net common stock issuance
74.32%5.88M
--0
104.37%1.06M
596.22%449.1K
89.53%4.37M
--3.37M
--483.84K
--517.84K
--64.51K
--2.31M
Net preferred stock issuance
----
----
----
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
4.83%4.7M
--2.69M
--1.93M
--0
-98.33%75.04K
--4.48M
--0
--0
---12.82K
--4.49M
Net other financing activities
----
----
----
----
----
37.52%-181.86K
89.04%-20.4K
---149
---17.25K
---144.06K
Cash from discontinued financing activities
Financing cash flow
37.86%10.58M
480.25%2.69M
478.02%2.99M
1,204.37%449.1K
-33.18%4.45M
671.33%7.67M
349.05%463.45K
593.04%517.69K
103.27%34.43K
--6.66M
Net cash flow
Beginning cash position
-2.05%2.24M
20.76%3.76M
-18.64%2.85M
-32.44%4.29M
-2.05%2.24M
-87.09%2.29M
-27.07%3.11M
-50.54%3.5M
-49.40%6.36M
-87.09%2.29M
Current changes in cash
4,761.05%2.44M
206.62%904.28K
324.09%917.4K
49.52%-1.44M
-49.33%2.06M
99.66%-52.31K
56.22%-848.1K
85.61%-409.38K
48.11%-2.85M
178.95%4.06M
Effect of exchange rate changes
-128.00%-1.5K
169.22%15.61K
-151.94%-9.62K
-384.02%-3.57K
-148.21%-3.92K
153.42%5.35K
45.54%-22.56K
-39.44%18.52K
-93.93%1.26K
140.90%8.14K
End cash Position
108.72%4.68M
108.72%4.68M
20.76%3.76M
-18.64%2.85M
-32.44%4.29M
-2.05%2.24M
-2.05%2.24M
-27.07%3.11M
-50.54%3.5M
-49.40%6.36M
Free cash flow
-5.38%-8.14M
-36.09%-1.78M
-123.82%-2.07M
34.58%-1.89M
7.96%-2.39M
45.20%-7.73M
25.10%-1.31M
66.17%-927.07K
35.31%-2.89M
49.47%-2.6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -5.38%-8.14M-36.09%-1.78M-123.82%-2.07M34.58%-1.89M7.96%-2.39M45.18%-7.73M25.10%-1.31M66.17%-927.07K35.31%-2.89M49.42%-2.6M
Net income from continuing operations 8.39%-8.77M30.45%-2.19M10.09%-1.87M-34.04%-2.52M11.07%-2.18M44.63%-9.57M8.19%-3.15M26.16%-2.08M70.43%-1.88M47.47%-2.46M
Operating gains losses 94.42%-2.57K--0--0--088.03%-2.57K95.55%-45.99K99.19%-6.6K100.10%623-103.11%-18.57K88.30%-21.44K
Depreciation and amortization -40.48%200.86K-52.13%39.49K-52.40%40.37K-52.84%39.98K-5.13%81.02K-17.29%337.49K-2.36%82.49K-11.50%84.81K-25.88%84.78K-24.64%85.41K
Other non cash items -123.73%-99.23K--29.45K-------------77.37%418.2K----------------
Change In working capital 30.08%-295.94K-88.59%100.14K-142.73%-299.95K126.48%382.8K14.00%-478.92K-142.20%-423.24K326.23%877.34K188.11%701.91K-584.66%-1.45M39.63%-556.89K
-Change in prepaid assets 40.58%250.94K-35.15%118.14K-84.34%84.6K-56.23%94.32K93.93%-46.13K2,703.12%178.5K-75.35%182.17K47.63%540.15K-50.74%215.47K50.99%-759.29K
-Change in payables and accrued expense 9.12%-546.88K-102.59%-18.01K-337.73%-384.56K117.37%288.48K-313.84%-432.8K-479.44%-601.74K230.29%695.17K243.52%161.76K-1,392.22%-1.66M-69.04%202.4K
Cash from discontinued investing activities
Operating cash flow -5.38%-8.14M-36.09%-1.78M-123.82%-2.07M34.58%-1.89M7.96%-2.39M45.18%-7.73M25.10%-1.31M66.17%-927.07K35.31%-2.89M49.42%-2.6M
Investing cash flow
Cash flow from continuing investing activities 00000
Net PPE purchase and sale ----------------------0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow ----------------------0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 37.86%10.58M480.25%2.69M478.02%2.99M1,204.37%449.1K-33.18%4.45M671.33%7.67M349.05%463.45K593.04%517.69K103.27%34.43K6.66M
Net common stock issuance 74.32%5.88M--0104.37%1.06M596.22%449.1K89.53%4.37M--3.37M--483.84K--517.84K--64.51K--2.31M
Net preferred stock issuance ----------------------0--0--0--------
Proceeds from stock option exercised by employees 4.83%4.7M--2.69M--1.93M--0-98.33%75.04K--4.48M--0--0---12.82K--4.49M
Net other financing activities --------------------37.52%-181.86K89.04%-20.4K---149---17.25K---144.06K
Cash from discontinued financing activities
Financing cash flow 37.86%10.58M480.25%2.69M478.02%2.99M1,204.37%449.1K-33.18%4.45M671.33%7.67M349.05%463.45K593.04%517.69K103.27%34.43K--6.66M
Net cash flow
Beginning cash position -2.05%2.24M20.76%3.76M-18.64%2.85M-32.44%4.29M-2.05%2.24M-87.09%2.29M-27.07%3.11M-50.54%3.5M-49.40%6.36M-87.09%2.29M
Current changes in cash 4,761.05%2.44M206.62%904.28K324.09%917.4K49.52%-1.44M-49.33%2.06M99.66%-52.31K56.22%-848.1K85.61%-409.38K48.11%-2.85M178.95%4.06M
Effect of exchange rate changes -128.00%-1.5K169.22%15.61K-151.94%-9.62K-384.02%-3.57K-148.21%-3.92K153.42%5.35K45.54%-22.56K-39.44%18.52K-93.93%1.26K140.90%8.14K
End cash Position 108.72%4.68M108.72%4.68M20.76%3.76M-18.64%2.85M-32.44%4.29M-2.05%2.24M-2.05%2.24M-27.07%3.11M-50.54%3.5M-49.40%6.36M
Free cash flow -5.38%-8.14M-36.09%-1.78M-123.82%-2.07M34.58%-1.89M7.96%-2.39M45.20%-7.73M25.10%-1.31M66.17%-927.07K35.31%-2.89M49.47%-2.6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Following the collapse of peace talks between the US and Iran, the US Central Command announced a full blockade of all vessels entering and Show More